Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era. (June 2022)

Record Type:: Journal Article
Title:: Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era. (June 2022)
Main Title:: Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
Authors:: Coates, Laura C
O'Dwyer, John
Meads, David
Emery, Paul
Conaghan, Philip G
Helliwell, Philip S
Abstract:
Is Part Of:: Lancet. Volume 4:Number 6(2022)
Journal:: Lancet
Issue:: Volume 4:Number 6(2022)
Issue Display:: Volume 4, Issue 6 (2022)
Year:: 2022
Volume:: 4
Issue:: 6
Issue Sort Value:: 2022-0004-0006-0000
Page Start:: e390
Page End:: e391
Publication Date:: 2022-06
Subjects:: Rheumatology -- periodicals
616.72305
Journal URLs:: https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2665-9913(22)00101-1 ↗
Languages:: English
ISSNs:: 2665-9913
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21567.xml